Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fagin

Showing results (181-190 of 261) with videos related to

Pageof 27
Sort By:
Biomedicines|April 23, 2022
BRAF<sup>V600E</sup> Induction in Thyrocytes Triggers Important Changes in the miRNAs Content and the Populations of Extracellular Vesicles Released in Thyroid Tumor MicroenvironmentOphélie Delcorte, Catherine Spourquet, Pascale Lemoine, et al.
The Journal of Clinical Endocrinology and Metabolism|August 21, 2008
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentificationRebecca E Schweppe, Joshua P Klopper, Christopher Korch, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 11, 2016
Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusionSnjezana Dogan, Lu Wang, Ryan N Ptashkin, et al.
Molecular Cancer|December 8, 2022
Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitorsMaria E R Garcia-Rendueles, Gnana Krishnamoorthy, Mahesh Saqcena, et al.
Histopathology|August 27, 2021
Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 casesBin Xu, Julia David, Snjezana Dogan, et al.
Cancer Cell|August 16, 2016
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF SignalingZoi Karoulia, Yang Wu, Tamer A Ahmed, et al.
Cancer Letters|May 18, 2004
Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomasMarina N Nikiforova, Raffaele Ciampi, Giuliana Salvatore, et al.
Thyroid : Official Journal of the American Thyroid Association|January 6, 2025
High-Grade Follicular Cell-Derived Non-Anaplastic Thyroid Carcinoma: Correlating Extent of Invasion and Mutation Profile with Oncologic OutcomeDaniel W Scholfield, Bin Xu, Helena Levyn, et al.
Cancer|June 30, 2017
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancerEric J Sherman, Lara A Dunn, Alan L Ho, et al.
Molecular Cancer Research : MCR|July 21, 2023
Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric EffectsIñigo Landa, Caitlin E M Thornton, Bin Xu, et al.
Pageof 27

Showing results (181-190 of 261) with videos related to

Sort By:
Pageof 27
Biomedicines|April 23, 2022
BRAF<sup>V600E</sup> Induction in Thyrocytes Triggers Important Changes in the miRNAs Content and the Populations of Extracellular Vesicles Released in Thyroid Tumor MicroenvironmentOphélie Delcorte, Catherine Spourquet, Pascale Lemoine, et al.
The Journal of Clinical Endocrinology and Metabolism|August 21, 2008
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentificationRebecca E Schweppe, Joshua P Klopper, Christopher Korch, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 11, 2016
Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusionSnjezana Dogan, Lu Wang, Ryan N Ptashkin, et al.
Molecular Cancer|December 8, 2022
Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitorsMaria E R Garcia-Rendueles, Gnana Krishnamoorthy, Mahesh Saqcena, et al.
Histopathology|August 27, 2021
Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 casesBin Xu, Julia David, Snjezana Dogan, et al.
Cancer Cell|August 16, 2016
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF SignalingZoi Karoulia, Yang Wu, Tamer A Ahmed, et al.
Cancer Letters|May 18, 2004
Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomasMarina N Nikiforova, Raffaele Ciampi, Giuliana Salvatore, et al.
Thyroid : Official Journal of the American Thyroid Association|January 6, 2025
High-Grade Follicular Cell-Derived Non-Anaplastic Thyroid Carcinoma: Correlating Extent of Invasion and Mutation Profile with Oncologic OutcomeDaniel W Scholfield, Bin Xu, Helena Levyn, et al.
Cancer|June 30, 2017
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancerEric J Sherman, Lara A Dunn, Alan L Ho, et al.
Molecular Cancer Research : MCR|July 21, 2023
Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric EffectsIñigo Landa, Caitlin E M Thornton, Bin Xu, et al.
Pageof 27